Polpharma Biologics

Gdansk, Poland Founded: 2011 • Age: 15 yrs
Develops and manufactures biosimilar drugs and CDMO services for biotechnology applications.
Request Access

About Polpharma Biologics

Polpharma Biologics is a company based in Gdansk (Poland) founded in 2011. It operates as a B2B, and CDMO Services. Polpharma Biologics offers products and services including Biosimilar Drugs, Cell Lines, and CDMO Services. Polpharma Biologics operates in a competitive market with competitors including Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and MabPlex, among others.

  • Headquarter Gdansk, Poland
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Polpharma Biologics S.A.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Polpharma Biologics

Polpharma Biologics offers a comprehensive portfolio of products and services, including Biosimilar Drugs, Cell Lines, and CDMO Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Medications similar to original biologics for cost-effective patient treatments.

Platforms for developing and licensing biosimilar drugs externally.

Customized development and production services for biosimilars and molecules.

People of Polpharma Biologics
Headcount 1-10
Employee Profiles 74
Employee Profiles
People
Michał Kruszewski
Head Of Information Security
People
Jacek Koryciński
IT Operations And Support Manager
People
Theodoros Zografou
Senior Director Business Development
People
Tina Danielzik
Product Quality Lead

Unlock access to complete

Funding Insights of Polpharma Biologics

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Polpharma Biologics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Polpharma Biologics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Polpharma Biologics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Polpharma Biologics

Polpharma Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and MabPlex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Mammalian cell culture biologics are developed through contract research services.
domain founded_year HQ Location
Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs
domain founded_year HQ Location
Contract manufacturing solutions for biologics are provided to Asian companies.
domain founded_year HQ Location
Drug substance development, analytical, and compliance services are provided.
domain founded_year HQ Location
Biologics development and GMP manufacturing services are offered.
domain founded_year HQ Location
Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Polpharma Biologics

Frequently Asked Questions about Polpharma Biologics

When was Polpharma Biologics founded?

Polpharma Biologics was founded in 2011.

Where is Polpharma Biologics located?

Polpharma Biologics is headquartered in Gdansk, Poland. It is registered at Gdansk, Pomeranian Voivodeship, Poland.

What does Polpharma Biologics do?

Polpharma Biologics is a biotechnology company specializing in the development and production of biosimilar drugs and innovative molecules. It offers CDMO services for biosimilars, utilizing state-of-the-art facilities in Poland and the Netherlands. The company collaborates with global partners to improve patient access to affordable therapies through research, clinical trials, and manufacturing. Its activities focus on high-quality biologics for various therapeutic areas, ensuring compliance with international standards.

Who are the top competitors of Polpharma Biologics?

Polpharma Biologics's top competitors include Avid Bioservices, Bionova Scientific and Rentschler Biopharma.

What products or services does Polpharma Biologics offer?

Polpharma Biologics offers Biosimilar Drugs, Cell Lines, and CDMO Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available